These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 34422881)
21. Inflammatory bowel disease, gut bacteria and probiotic therapy. Reiff C; Kelly D Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289 [TBL] [Abstract][Full Text] [Related]
22. Gut microbiota and inflammatory bowel disease: so far so gut! Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937 [TBL] [Abstract][Full Text] [Related]
23. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications. Shamoon M; Martin NM; O'Brien CL Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403 [TBL] [Abstract][Full Text] [Related]
24. The potential impact of gut microbiota on your health:Current status and future challenges. Sirisinha S Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926 [TBL] [Abstract][Full Text] [Related]
25. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? Bringiotti R; Ierardi E; Lovero R; Losurdo G; Di Leo A; Principi M World J Gastrointest Pathophysiol; 2014 Nov; 5(4):550-9. PubMed ID: 25400998 [TBL] [Abstract][Full Text] [Related]
26. A dietary intervention to improve the microbiome composition of pregnant women with Crohn's disease and their offspring: The MELODY (Modulating Early Life Microbiome through Dietary Intervention in Pregnancy) trial design. Peter I; Maldonado-Contreras A; Eisele C; Frisard C; Simpson S; Nair N; Rendon A; Hawkins K; Cawley C; Debebe A; Tarassishin L; White S; Dubinsky M; Stone J; Clemente JC; Sabino J; Torres J; Hu J; Colombel JF; Olendzki B Contemp Clin Trials Commun; 2020 Jun; 18():100573. PubMed ID: 32617430 [TBL] [Abstract][Full Text] [Related]
27. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention. Aleksandrova K; Romero-Mosquera B; Hernandez V Nutrients; 2017 Aug; 9(9):. PubMed ID: 28867793 [TBL] [Abstract][Full Text] [Related]
28. [Insights into the Pathogenesis of Inflammatory Bowel Diseases: Genetics and Microbiota]. Marchukov D; Misselwitz B Ther Umsch; 2019 Jan; 75(5):273-279. PubMed ID: 30700240 [TBL] [Abstract][Full Text] [Related]
29. Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases. Li H; Christman LM; Li R; Gu L Food Funct; 2020 Jun; 11(6):4878-4891. PubMed ID: 32490857 [TBL] [Abstract][Full Text] [Related]
30. The Microbiome in Patients With Inflammatory Diseases. Somineni HK; Kugathasan S Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163 [TBL] [Abstract][Full Text] [Related]
31. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response. Thompson-Chagoyán OC; Maldonado J; Gil A Clin Nutr; 2005 Jun; 24(3):339-52. PubMed ID: 15896420 [TBL] [Abstract][Full Text] [Related]
34. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781 [TBL] [Abstract][Full Text] [Related]
35. Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease. Pavel FM; Vesa CM; Gheorghe G; Diaconu CC; Stoicescu M; Munteanu MA; Babes EE; Tit DM; Toma MM; Bungau S Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34203609 [TBL] [Abstract][Full Text] [Related]
36. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet? Serban DE Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390 [TBL] [Abstract][Full Text] [Related]
37. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711 [TBL] [Abstract][Full Text] [Related]
38. Probiotics in early life: a preventative and treatment approach. Hashemi A; Villa CR; Comelli EM Food Funct; 2016 Apr; 7(4):1752-68. PubMed ID: 26979945 [TBL] [Abstract][Full Text] [Related]
39. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction. Zhou Y; Xu ZZ; He Y; Yang Y; Liu L; Lin Q; Nie Y; Li M; Zhi F; Liu S; Amir A; González A; Tripathi A; Chen M; Wu GD; Knight R; Zhou H; Chen Y mSystems; 2018; 3(1):. PubMed ID: 29404425 [TBL] [Abstract][Full Text] [Related]
40. Urbanization and the gut microbiota in health and inflammatory bowel disease. Zuo T; Kamm MA; Colombel JF; Ng SC Nat Rev Gastroenterol Hepatol; 2018 Jul; 15(7):440-452. PubMed ID: 29670252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]